Biogen Inc. (BIIB) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-05 (expected, before the open). EPS estimate 2.79, revenue estimate 2.61B.
Over the last 12 reports the stock moved 3.7% on average (either way), rising 7 times and falling 5. EPS beat estimates 11 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-28 | 2.62 | 1.99 | +31.7% | 2.80B | 2.63B | -1.2% |
| Q2 FY2026 | 2026-07-29 | 3.60 | 2.94 | +22.4% | 2.74B | 2.46B | +1.1% |
| Q1 FY2026 | 2026-04-29 | 3.57 | 3.05 | +17.0% | 2.48B | 2.29B | +3.2% |
| Q4 FY2025 | 2026-02-06 | 1.99 | 1.63 | +22.1% | 2.28B | 2.20B | +4.6% |
| Q3 FY2025 | 2025-10-30 | 4.81 | 3.88 | +24.0% | 2.45B | 2.34B | +4.3% |
| Q2 FY2025 | 2025-07-31 | 5.47 | 3.90 | +40.3% | 2.65B | 2.33B | +4.2% |
| Q1 FY2025 | 2025-05-01 | 3.02 | 2.90 | +4.1% | 2.43B | 2.23B | +2.0% |
| Q4 FY2024 | 2025-02-12 | 3.44 | 3.43 | +0.3% | 2.45B | 2.41B | -0.7% |